Technical Analysis for HEB - Hemispherx BioPharma, Inc.

Grade Last Price % Change Price Change
grade F 3.9499 -2.47% -0.10
HEB closed down 2.47 percent on Friday, July 19, 2019, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical HEB trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish -2.47%
Bollinger Band Squeeze Range Contraction -2.47%
Inside Day Range Contraction -2.47%
20 DMA Resistance Bearish -2.95%
Pocket Pivot Bullish Swing Setup -2.95%
Bollinger Band Squeeze Range Contraction -2.95%

Older signals for HEB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Medicine Medical Specialties Pharmaceutical Infectious Diseases Influenza HIV Hepatitis B Renal Cell Carcinoma Drug Therapies Viral Diseases Antivirals Interferon Chronic Disorders
Is HEB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.8104
52 Week Low 3.62
Average Volume 175,279
200-Day Moving Average 7.7495
50-Day Moving Average 4.9147
20-Day Moving Average 4.1296
10-Day Moving Average 4.0423
Average True Range 0.4449
ADX 20.97
+DI 22.0976
-DI 14.8445
Chandelier Exit (Long, 3 ATRs ) 3.3453
Chandelier Exit (Short, 3 ATRs ) 4.9547
Upper Bollinger Band 4.4568
Lower Bollinger Band 3.8024
Percent B (%b) 0.23
BandWidth 15.846571
MACD Line -0.2556
MACD Signal Line -0.3092
MACD Histogram 0.0536
Fundamentals Value
Market Cap 115.25 Million
Num Shares 29.2 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -10.76
Price-to-Sales 27.86
Price-to-Book 0.90
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.18
Resistance 3 (R3) 4.19 4.12 4.14
Resistance 2 (R2) 4.12 4.07 4.12 4.13
Resistance 1 (R1) 4.04 4.03 4.01 4.03 4.11
Pivot Point 3.97 3.97 3.96 3.97 3.97
Support 1 (S1) 3.89 3.92 3.85 3.87 3.79
Support 2 (S2) 3.82 3.88 3.82 3.77
Support 3 (S3) 3.74 3.82 3.76
Support 4 (S4) 3.72